LAVA Therapeutics NV

+0.11 (+1.78%)
7:46:56 PM EDT: $6.25 -0.03 (-0.48%)
Earnings Announcements

LAVA Therapeutics Provides Business Update, Reports Third Quarter Financial Results

Published: 11/16/2022 21:30 GMT
LAVA Therapeutics NV (LVTX) - Lava Therapeutics Provides Business Update and Reports Third Quarter Financial Results.
Lava Therapeutics NV Q3 Earnings per Share $0.04.
Lava Therapeutics- Cash &investments of $92.7 Million As of September 30, Plus$50.0 Million Received From Seagen in Oct Provide Cash Runway Beyond 2024.
Lava Therapeutics NV - Qtrly Research and License Revenue $15.3 Million.
Revenue is expected to be $1.2 Million
Adjusted EPS is expected to be -$0.60

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.